-
1دورية أكاديمية
المؤلفون: Sun, Rui-Juan, Wei, Zhi-Jie, Liu, De-Yan, Cao, Xing-Yu, Zhang, Jian-Ping, Xiong, Min, Zhao, Yan-Li, Zhou, Jia-Rui, Lu, Yue, Lu, Pei-Hua, Lu, DaoPei
المصدر: Biology of Blood and Marrow Transplantation ; volume 25, issue 3, page S111-S112 ; ISSN 1083-8791
مصطلحات موضوعية: Transplantation, Hematology
الإتاحة: https://doi.org/10.1016/j.bbmt.2018.12.387Test
https://api.elsevier.com/content/article/PII:S1083879118312096?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1083879118312096?httpAccept=text/plainTest -
2دورية أكاديمية
المؤلفون: Zhang, Xian, Wu, Shulan, Yang, Junfang, Zhang, Gailing, Su, Yunchao, Zhang, Min, He, Jiujiang, Shi, Yanze, Li, Wenqian, Lu, Peihua, Lu, Daopei
المصدر: International Journal of Hematology; Apr2023, Vol. 117 Issue 4, p530-537, 8p
-
3دورية أكاديمية
المؤلفون: Zhang, Xian, Wu, Shulan, Yang, Junfang, Zhang, Gailing, Su, Yunchao, Zhang, Min, He, Jiujiang, Shi, Yanze, Li, Wenqian, Lu, Peihua, Lu, Daopei
المصدر: International Journal of Hematology ; volume 117, issue 4, page 530-537 ; ISSN 0925-5710 1865-3774
مصطلحات موضوعية: Hematology
-
4
-
5دورية أكاديمية
المؤلفون: Yang, Fan, Lu, Daopei, Hu, Yu, Huang, Xiaojun, Huang, He, Chen, Jing, Wu, Depei, Wang, Jianmin, Wang, Chun, Han, Mingzhe, Chen, Hu
المساهمون: Chen, H (reprint author), Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China., Lu, DP (reprint author), Hebei Yanda Ludaopei Hosp, Langfang, Hebei, Peoples R China., Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China., Hebei Yanda Ludaopei Hosp, Langfang, Hebei, Peoples R China., Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Hebei, Peoples R China., Peking Univ, Peoples Hosp, Beijing, Peoples R China., Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China., Shanghai Childrens Med Ctr, Shanghai, Peoples R China., Soochow Univ, Affiliated Hosp 1, Suzhou, Zhejiang, Peoples R China., Changhai Hosp Shanghai, Shanghai, Peoples R China., Shang Hai Gen Hosp, Shanghai, Peoples R China., Chinese Acad Med Sci, Inst Hematol & Hosp Blood Dis, Tianjin, Peoples R China., Peking Union Med Coll, Tianjin, Peoples R China.
المصدر: SCI
مصطلحات موضوعية: Graft vs. Host Disease, Whole-Body Irradiation, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells, ACUTE MYELOID-LEUKEMIA, MATCHED SIBLING DONORS, BLOOD PROGENITOR CELLS, BONE-MARROW, ALLOGENEIC TRANSPLANTATION, MULTICENTER TRIAL, WORKING PARTY, T-CELL, INTENSITY, MISMATCH
العلاقة: ANNALS OF TRANSPLANTATION.2017,22,384-401.; 1906816; http://hdl.handle.net/20.500.11897/472644Test; WOS:000404632700001
الإتاحة: https://doi.org/20.500.11897/472644Test
https://doi.org/10.12659/AOT.902805Test
https://hdl.handle.net/20.500.11897/472644Test -
6تقرير
المصدر: Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04546893Test
-
7تقرير
المصدر: Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04447573Test
-
8تقرير
المصدر: Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04447547Test
-
9تقرير
المصدر: A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04129099Test
-
10تقرير
المؤلفون: LU DAOPEI MEDICAL, 960th Hospital of PLA, The Second Hospital of Hebei Medical University, The Second Affiliated Hospital of Dalian Medical University, Air Force Military Medical University, China
المساهمون: Daihong Liu, Director
المصدر: Kuzma Z, Eder S, Bohm A, Pernka E, Vormtag L, Kalhs P, Petkov V, Stary G, Nepp J, Knobler R, Just U, Krenn K, Worel N, Gre HT. Snantly worse surval of patnts wh N-defed chron graft-versus-host dease and thrombocytopen or progresse onset type: results of a prospecte study. Leukem. 2012 Apr;26(4):746-56. do 10.1038/leu.2011.257. Epub 2011 Sep 16.
Thepot S, Zhou J, Perrot A, Rob M, Xhaard A, de Latour RP, Ades L, Raud P, Petropoulou AD, Porcher R, Soc G. The graft-versus-leukem effect maly restrted to N-defed chron graft-versus-host dease after reduced tensy condng before allogene stem cell transplantatn. Leukem. 2010 Nov;24(11):1852-8. do 10.1038/leu.2010.187. Epub 2010 Sep 9.
Leve JE, Braun TM, Harr AC, Holler E, Taylor A, Mler H, Magenau J, Wedorf DJ, Ho VT, Bolanos-Meade J, AlousAM, Ferrara JL; Blood and Marrow Transplant Clal Trls Network. A prognost score for acute graft-versus-host dease based on bmarkers: a multentre study. Lancet Haematol. 2015 Jan;2(1):e21-9. do 10.1016/S2352-3026(14)00035-0. Epub 2014 Dec 23.
Major-Monfrd H, Renter AS, Pawarode A, Reddy P, Ayuk F, Holler E, Efebera YA, Hogan WJ, Wolfl M, Qayed M, Hexner EO, Wudharn K, Ordemann R, Young R, Shah J, Hartwell MJ, Chaudhry MS, Az M, Etra A, Yan GA, Kroger N, Weber D, Chen YB, Nakamura R, Rosler W, Kko CL, Harr AC, Pulsher M, Reshef R, Kowalyk S, Morales G, Torres Ozbek U, Ferrara JLM, Leve JE. MAG bmarkers predt long-term outcomes for stero-restant acute GVHD. Blood. 2018 Jun 21;131(25):2846-2855. do 10.1182/blood-2018-01-822957. Epub 2018 Mar 15.
von Bubnoff N, orst G, Grha O, Rothlg N, Bertz H, Duyster J, Fke J, Zeer R. Ruxol GvHD (R) study: a multenter, randomed phase 2 trl to determe the response rate of Ruxol and best avaable treatment (BAT) versus BAT stero-refractory acute graft-versus-host dease (aGvHD) (NCT02396628). BMC Cancer. 2018 Nov 19;18(1):1132. do 10.1186/s12885-018-5045-7.
Ruxolitinib in Combination With Corticosteroid as First Line Therapy for the Treatment of High Risk Acute Graft-Versus-Host Diseaseالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04061876Test